Laura Boullerot

464 total citations
17 papers, 260 citations indexed

About

Laura Boullerot is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Laura Boullerot has authored 17 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Laura Boullerot's work include Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Laura Boullerot is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immune Cell Function and Interaction (6 papers). Laura Boullerot collaborates with scholars based in France and South Korea. Laura Boullerot's co-authors include Olivier Adotévi, Caroline Laheurte, Marion Jacquin, Magalie Dosset, Éric Tartour, Charlée Nardin, Virginie Westeel, F. Aubin, Béatrice Gaugler and Elodie Lauret Marie Joseph and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and British Journal of Cancer.

In The Last Decade

Laura Boullerot

16 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Boullerot France 9 162 143 80 32 18 17 260
Aliyah M. Weinstein United States 7 200 1.2× 154 1.1× 49 0.6× 20 0.6× 14 0.8× 9 268
Muhammad Adnan Khattak Australia 9 101 0.6× 185 1.3× 77 1.0× 21 0.7× 23 1.3× 33 264
Sandra S. Ring Switzerland 6 117 0.7× 107 0.7× 54 0.7× 28 0.9× 9 0.5× 8 220
Hui-Juan Qiu China 7 194 1.2× 213 1.5× 88 1.1× 30 0.9× 30 1.7× 10 359
Tyler G. Searles United States 5 148 0.9× 169 1.2× 53 0.7× 31 1.0× 14 0.8× 7 235
Beny Shapiro Israel 5 158 1.0× 195 1.4× 157 2.0× 35 1.1× 45 2.5× 6 337
Vanesa de Luque Spain 3 158 1.0× 255 1.8× 69 0.9× 38 1.2× 10 0.6× 3 336
Maya Eisenring Switzerland 7 205 1.3× 97 0.7× 33 0.4× 33 1.0× 73 4.1× 11 282
Shuping Ding China 5 77 0.5× 106 0.7× 57 0.7× 26 0.8× 12 0.7× 7 177

Countries citing papers authored by Laura Boullerot

Since Specialization
Citations

This map shows the geographic impact of Laura Boullerot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Boullerot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Boullerot more than expected).

Fields of papers citing papers by Laura Boullerot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Boullerot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Boullerot. The network helps show where Laura Boullerot may publish in the future.

Co-authorship network of co-authors of Laura Boullerot

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Boullerot. A scholar is included among the top collaborators of Laura Boullerot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Boullerot. Laura Boullerot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Abhishek, Kumar, Francis Bonnefoy, Maxime Fredon, et al.. (2024). Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy. Frontiers in Immunology. 15. 1202017–1202017.
2.
Boullerot, Laura, et al.. (2023). Response to Chemoimmunotherapy Is Associated With Expansion of Systemic Antitumor CD4+ Th1 Response in Metastatic Non–Small Cell Lung Cancer. Journal of Immunotherapy. 46(7). 279–283. 2 indexed citations
3.
Carpentier, Alain, François Ghiringhelli, Rénata Ursu, et al.. (2023). Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study.. Journal of Clinical Oncology. 41(16_suppl). 2005–2005. 6 indexed citations
4.
Laheurte, Caroline, Laura Boullerot, Marine Malfroy, et al.. (2022). Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma. Cancer Immunology Immunotherapy. 72(3). 579–589. 5 indexed citations
5.
Kroemer, Marie, Laura Boullerot, Laurie Spehner, et al.. (2022). The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors. Frontiers in Public Health. 10. 816848–816848. 5 indexed citations
6.
Laheurte, Caroline, Marine Malfroy, Laura Boullerot, et al.. (2022). TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition. Frontiers in Immunology. 13. 932298–932298. 8 indexed citations
7.
Nardin, Charlée, Caroline Laheurte, E. Puzenat, et al.. (2021). Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma. Journal of Investigative Dermatology. 142(2). 435–444. 13 indexed citations
8.
Laheurte, Caroline, Laura Boullerot, Lucie Laurent, et al.. (2021). Inflammatory and immunological profile in COPD secondary to organic dust exposure. Clinical Immunology. 229. 108798–108798. 4 indexed citations
9.
Boullerot, Laura, Caroline Laheurte, Amandine Martin, et al.. (2020). Association of reinvigoration of circulating anti-telomerase CD4 Th1 response in cancer patients with anti-PD-1 response.. Journal of Clinical Oncology. 38(15_suppl). 3044–3044. 1 indexed citations
10.
Joseph, Elodie Lauret Marie, Caroline Laheurte, Marine Jary, et al.. (2019). Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer. Cancer Immunology Research. 8(2). 268–279. 33 indexed citations
11.
Laheurte, Caroline, Fabien Calcagno, Laura Boullerot, et al.. (2019). Metronomic cyclophosphamide induces regulatory T cells depletion and PSA‐specific T cells reactivation in patients with biochemical recurrent prostate cancer. International Journal of Cancer. 147(4). 1199–1205. 14 indexed citations
12.
Laheurte, Caroline, Magalie Dosset, Déwi Vernerey, et al.. (2019). Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. British Journal of Cancer. 121(5). 405–416. 67 indexed citations
13.
Cordonnier, M, Charlée Nardin, Laura Boullerot, et al.. (2019). Increased Levels of Interleukin-17A Exosomes in Psoriasis. Acta Dermato Venereologica. 99(12). 0–0. 37 indexed citations
14.
Boullerot, Laura, Thi Tran, Laura Mansi, et al.. (2018). Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy. International Journal of Cancer. 143(11). 3008–3018. 16 indexed citations
15.
Picard, Émilie, Yann Godet, Caroline Laheurte, et al.. (2018). Circulating NKp46+Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer. OncoImmunology. 8(2). e1527498–e1527498. 29 indexed citations
16.
Kroemer, Marie, Laurie Spehner, Laura Boullerot, et al.. (2017). SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts. OncoImmunology. 7(4). e1412030–e1412030. 3 indexed citations
17.
Galaine, Jeanne, Yves Claude Guillaume, Romain Boidot, et al.. (2016). Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells. The Journal of Immunology. 197(5). 1597–1608. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aliyah M. Weinstein Breakdown of academic impact, for papers by Muhammad Adnan Khattak Breakdown of academic impact, for papers by Sandra S. Ring Breakdown of academic impact, for papers by Hui-Juan Qiu Breakdown of academic impact, for papers by Tyler G. Searles Breakdown of academic impact, for papers by Beny Shapiro Breakdown of academic impact, for papers by Vanesa de Luque Breakdown of academic impact, for papers by Maya Eisenring Breakdown of academic impact, for papers by Shuping Ding
Rankless by CCL
2026